Royalty Pharma
RPRX
$42.56
Share price
-0.63%
Change (1 day)
1.58%
Change (1 year)
Categories
Revenue for Royalty Pharma (RPRX)
Revenue in 2022 (TTM): $2.27 B
According to Royalty Pharma's latest financial reports the company's current revenue (TTM) is $2.27 B. In 2021 the company made a revenue of $2.28 B an increase over the years 2020 revenue that were of $2.12 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Royalty Pharma from 2019 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 (TTM) | $2.27 B | -0.48% |
| 2021 | $2.28 B | 7.87% |
| 2020 | $2.12 B | 16.98% |
| 2019 | $1.81 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $44.51 B | 1,853.67% | 🇺🇸 USA |
 Eli Lilly LLY | $29.32 B | 1,186.94% | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | $0.22 B | -90.08% | 🇺🇸 USA |